SCOTS could soon have access to machines which provide coronavirus test results within 12 minutes.

Scotland's Trade Minister Ivan McKee says the units have the potential to "revolutionise the fight against the virus".

A minimum of 500,000 coronavirus tests will be available for use with 300 of the machines – if it is approved for use in Scotland – after the Scottish Government agreed a £6.76 million deal with UK-based firm LumiraDx.

Test strips for the machines will be made at the company's Stirling factory, creating jobs in Scotland, McKee told MSPs.

The Government said the portable design of the machines means they are well suited for local clinics and mobile units across Scotland's rural and island communities.

The test is able to detect Covid-19 antigen proteins from a nasal swab, with results in under 12 minutes in symptomatic patients.

It was authorised for emergency use by the US Federal Drug Administration last week and is going through the final stages of validation for use in Scotland and Europe.

READ MORE: Nicola Sturgeon confirms deaths of two coronavirus patients in Scotland

The Scottish Government also suggested that, following the initial order of 500,000 tests, a UK-wide agreement for future procurement is anticipated.

Announcing the purchase in the Scottish Parliament, McKee said the fast turnaround of test results will be "of huge importance to our test and protect strategy".

"This can revolutionise the fight against the virus," he said.

"Looking ahead, we expect continued developments in testing capability by making sample collection simpler and turnaround times quicker.

"We continue to work on supply chain resilience and on future needs, and progress has been made to develop rapid point-of-care or near point-of-care testing, especially in remote areas."

Chief executive and chairman of LumiraDx, Ron Zwanziger, added: "We designed our high-sensitivity platform to deliver fast, accurate and actionable diagnostic results near to the patient.

"We are proud to have a strong presence in Scotland with our research and manufacturing teams here and look forward to working with Scotland's health systems to address the Covid-19 crisis in a way that's affordable and accessible in community care settings."